Bücke, Philipp http://orcid.org/0000-0001-5204-2016
Henkes, Hans
Kaesmacher, Johannes
Heldner, Mirjam R.
Scutelnic, Adrian
Arnold, Marcel
Meinel, Thomas R.
Cimpoca, Alexandru
Horvath, Thomas
Henkes, Elina
Bäzner, Hansjörg
Hellstern, Victoria
Funding for this research was provided by:
University of Bern
Article History
Received: 18 February 2024
Accepted: 7 June 2024
First Online: 23 July 2024
Conflicts of interest
: HH has a consultancy agreement with Phenox GmbH | Wallaby Medical and is co-founder and shareholder of CONTARA GmbH. MA reports speaker honoraria from Astra Zeneca, Bayer, Covidien, Medtronic, Sanofi and honoraria for scientific advisory boards from Amgen, Bayer, BMS, Daiichi Sankyo, Medtronic, and Pfizer, and research funding from the Swiss National Science Foundation, and the Swiss Heart Foundation. TRM reports grants from Bangerter-Rhyner Foundation during the conduct of the study. VH has a consultant and proctoring agreement with Phenox GmbH. All other authors report no disclosures relevant to the article.
: This study was approved by the local institutional review boards (Ethics Commission of the State Medical Association of Baden-Württemberg [F-2012-077]; Kantonale Ethikkommission Bern [231/14]). Additional approval and patient consent was required for inclusion in the EVT registry (Stuttgart).